Bibliografía
1 Rao MC, Sarathy J, Sellin JH. Intestinal electrolyteabsorption and secretion. In Sleissen- ger and Fordtran´s. Gastroientestinal and Liverdisease. 10th ed, ELSEVIER 2016, chapter 101, pp 1713-34.
2 Bohn L, Storsrud S, Tornblom H, et al. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol 2013;108:634-41.
3 Simren M, Mansson A, Langkilde AM. et al. Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion 2001;63:108–15.
4 Monsbakken KW, Vandvik PO, Farup PG. Perceived food intolerance in subjects with irritable bowel syndrome-- etiology, prevalence and consequences. Eur J Clin Nutr 2006;60:667–72.
5 El-Salhy M, Ostgaard H, Gundersen D, et al. The role of diet in the pathogenesis and management of irritable bowel syndrome. Int J Mol Med 2012;29:723-31.
6 Dapoigny M, Stockbrügger RW, Azpiroz F, Collins S, Coremans G, MüllerLissner S, et al. Role of alimentation in irritable bowel syndrome. Digestion 2003; 67:225–233.
7 Park MI, Camilleri M. Is there a role of food allergy in irritable bowel syndrome and functional dyspepsia? A systematic review. Neurogastroenterol Motil 2006;18:595-607
8 Biesiekierski JR, Peters SL, Newnham ED, et al. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology 2013;145:320-8.
9 Eswaran S, Goel A, Chey WD. What role does wheat play in the symptoms of irritable bowel syndrome? Gastroenterol Hepatol (N Y) 2013;9:85-91.
10 Cenac N, Bautzova T, Le Faouder P, et al. Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome. Gastroenterology 2015;149:433-44.
11 Wu GD, Bushmanc FD, Lewis JD. Diet, the human gut microbiota, and IBD. Anaerobe 2013;24:117-20.
12. Ahmed S, Macfarlane GT, Fite A, McBain AJ, Gilbert P, Macfarlane S. Mucosa-associ- ated bacterial diversity in relation to human terminal ileum and colonic biopsy samples. Appl Environ Microbiol 2007;73:7435-42.
13. Mowat AM, Agace WW. Regional specialization within the intestinal immune system. Nat Rev Immunol 2014;14:667-85.
14. Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature 2012;486:222-7.
15. Zimmer J, Lange B, Frick JS, et al. A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur J Clin Nutr 2012;66:53-60.
16. Claesson MJ, Jeffery IB, Conde S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012;488:178-84.
17. Krishnan S, Alden N, Lee K. Pathways and functions of gut microbiota metabolism impacting host physiology. Curr Opin Biotechnol 2015;36:137-45.
18. Tana C, Umesaki Y, Imaoka A, et al. Altered profiles of intestinal microbiota and or- ganic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroen- terol Motil 2010;22:512-9,
19. Vital M, Howe AC, Tiedje JM. Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data. MBio 2014;5:e00889.
20. Miller TL, Wolin MJ. Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora. Appl Environ Microbiol 1996;62:1589-92.
41. Monsbakken KW, Vandvik PO, Farup PG. Perceived food intolerance in subjects with irritable bowel syndrome etiology, prevalence and consequences. Eur J Clin Nutr 2006;60:667-72.
42. Berg LK, Fagerli E, Myhre AO, Florholmen J, Goll R. Self-reported dietary fructose intolerance in irritable bowel syndrome: Proposed diagnostic criteria. World J Gastroen- terol.2015;21:5677-84.
43. Vincenzi M, Del Ciondolo I, Pasquini E, Gennai K, Paolini B. Effects of a Low FODMAP Diet and Specific Carbohydrate Diet on Symptoms and Nutritional Adequacy of Patients with Irritable Bowel Syndrome: Preliminary Results of a Single-blinded Randomized Trial. J Transl Int Med 2017;5:120-6.
44. Makharia A, Catassi C, Makharia GK. The Overlap between Irritable Bowel Syndrome and Non-Celiac Gluten Sensitivity: A Clinical Dilemma. Nutrients 2015; 7:10417-26.
45. Durchschein F, Petritsch W, Hammer HF. Diet therapy for inflammatory bowel diseas- es: The established and the new. World J Gastroenterol 2016;22:2179-94.
46. Halpert A, Dalton CB, Palsson O, et al. What patients know about irritable bowel syndrome (IBS) and what they would like to know. National Survey on Patient Educa- tional Needs in IBS and development and validation of the Patient Educational Needs Questionnaire (PEQ). Am J Gastroenterol 2007;102:1972-82.
47. Gibson PR, Shepherd SJ. Personal view: food for thought—western lifestyle and sus- ceptibility to Crohn’s disease. The FODMAP hypothesis. Aliment Pharmacol Ther 2005;21: 1399-409.
48. McKenzie YA, Bowyer RK, Leach H,, et al. British Dietetic Association systematic re- view and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults. J Hum Nutr Diet 2016; 29:549-75.
49. National Institute for Health and Clinical Excellence. Irritable bowel syndrome in adults: diagnosis and management. Clinical Guideline [CG61]. Published: February 2008. Last updated: February 2015. Cited 2017-01-03. Available from: URL: https://www.nice. org.uk/guidance/cg61/resources/irritable bowel syndrome-in-adults-diagnosis-and-man- agement-975562917829
50. Halmos EP. When the low FODMAP diet does not work. J Gastroenterol Hepatol. 2017;1: 69-72.
51. Harvie RM, Chisholm AW, Bisanz JE, et al. Long-term irritable bowel syndrome symp- tom control with reintroduction of selected FODMAPs Randomized Controlled Trial. World J Gastroenterol 2017; 23:4632-43.
52. Murray K, Wilkinson-Smith V, Hoad C et al. Differential effects of FODMAPs ferment- able oligo-, di-, mono-saccharides and polyols on small and large intestinal contents in healthy subjects shown by MRI. Am J Gastroenterol 2014;109:110–9.
53. Barrett JS, Gearry RB, Muir JG et al. Dietary poorly absorbed, short-chain carbohy- drates increase delivery of water and fermentable substrates to the proximal colon. Ali- ment Pharmacol Ther 2010;31:874- 82.
54. Ong DK, Mitchell SB, Barrett JS et al. Manipulation of dietary short chain carbohy- drates alters the pattern of gas production and genesis of symptoms in irritable bowel syndrome. J Gastroenterol Hepatol 2010;25:1366-73.
55. McKenzie YA, Alder A, Anderson W et al. British Dietetic Association evidence-based guidelines for the dietary management of irritable bowel syndrome in adults. J Hum Nutr Diet 2012;25:260–74.
56. Halmos EP, Power VA, Shepherd SJ et al. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 2014;146:e5.
57. Staudacher HM, Lomer MC, Anderson JL et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr 2012;142:1510-18.
58. Böhn L, Störsrud S, Liljebo T et al. Diet low in FODMAPs reduces symptoms of irrita- ble bowel syndrome as well as traditional dietary advice: A randomized controlled trial. Gastroenterology 2015;149:1399-407.
59. Pedersen N, Andersen NN, Vegh Z et al. Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome. World J Gastroenterol 2014;20:16215-26.
60. Berg LK, Fagerli E, Martinussen M, et al. Effect of fructose-reduced diet in patients with irritable bowel syndrome, and its correlation to a standard fructose breath test. Scand J Gastroenterol. 2013;48:936-43.
61. Rao SSC, Yu S, Fedewa A. Systematic review: dietary fibre and FODMAP-restricted diet in the management of constipation and irritable bowel síndrome. Aliment Pharmacol Ther 2015;41:1256-70.
62. Hill P, Muir JG, Gibson PR. Controversies and Recent developments of the Low- FODMAP Diet. Gastroenterology Hepatology 2017;13:36-45.
63. Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: The FODMAP approach. J Gastroenterol Hepatol 2010;25:252-8.
64. Halmos EP, Christophersen CT, Bird AR et al. Diets that differ in their FODMAP con- tent alter the colonic luminal microenvironment. Gut 2015;64:93-100.
65. Staudacher Nutritional, microbiological and psychosocial implications of the low FODMAP diet. J Gastroenterol Hepatol 2017; 32 (Suppl. 1): 16-9.
66. Parkes GC, Rayment NB, Hudpith BN, et al. Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome. Neurogastroenterol Motil 2012;24:31-9.
67. Jalanka-Tuovinen J, Salonen A, Nikkilä J, et al. Intestinal microbiota in healthy adults: temporal analysis reveals individual and common core and relation to intestinal symptoms. PLoS One 2011;6:e23035.
68. Rajilic-Sotjanovic M, Biagi E, Heilig HG, et al. Global and deep molecular analysis of microbiota signatures in faecal samples from patients with irritable bowel syndrome. Gastroenterology 2011;141:1737-801.
69. Deng Y, Misselwitz B, Dai N, Fox M. Lactose intolerance in adults: biological mecha- nism and dietary management. Nutrients 2015;7:8020-35.
70. La Orden Izquierdo E, Carabaño Aguado I, Pelayo García FJ. Situación actu- al de la intolerancia a la lactosa en la infancia. Rev Pediatr Aten Primaria. 2011;13:271-8.
71. Szilagyi A. Adaptation to lactose in lactase non persistent people: effects on intol- erance and the relationship between dairy food consumption and evaluation diseas- es. Nutrients 2015;7:6751-79.
72. Pal S, Woodford K, Kukuljan S, Ho S. Milk intolerance. Beta casein and lactose. Nu- trients 2015;7:7285-97.
73. Crittenden RGI, Bennett LE. Cow’s milk allrgya: a complex disorder. J Am Coll Nutr [Internet]. 2005;24(6 suppl):582S-91S.
74. Arroyo Villarino M, Alcedo González J. Intolerancia a la lactosa: diagnóstico y trat- amiento. JANO. 2004;66:956-60.
75. Hargrove JL, Berdanier CD. Nutrition and gene expression. Boca Raton: CRC Press; 1993
76. Deng Y, Misselwitz B, Dai N, Fox M. Lactose intolerance in adults: biological mech- anism and dietary management. Nutrients 2015;7:8020-35.
77. Zhu Y, Zheng X, Cong Y, Chu H, Fried M, Dai N, et al. Bloating and distention in irritable Bowel Syndrome: the role of gas production and visceral sensation after lactose ingestion in a population with lactase deficiency [Abstract]. Am J Gastroenterol 2013;108:1516-25.
78. Porras R, López-Colombo A, Schmulson M. Increase in Mexican and Latin American scientific articles on irritable bowel syndrome. Rev Gastroenterol Mex 2015;80:228–35.
79. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012;10, e4.
80. Fasano A, Sapone A, Zevallos V et al. Non-celiac Gluten Sensitivity. Gastroenterology. 2015;148:1195-204.
81. McKenzie YA, Bowyer RK, Leach P et al. British Dietetic Association systematic re- view and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults. J Hum Nutr Diet 2016; 29:549-75.
82. Makharia A, Catassi C, Makharia GK. The Overlap between Irritable Bowel Syndrome and Non-Celiac Gluten Sensitivity: A Clinical Dilemma. Nutrients 2015;10:10417-26.
83. Rodrigo-Sáez L, Fuentes-Álvarez D, Álvarez-Mieres N et al. Enfermedad Celiaca en el 2009. RAPD Online 2009;32:339-57.
84. Lucendo AJ, García-Manzanares A, Arias A et al. Coeliac Disease in the 21st Centu- ry: No Longer “Kids’ Stuff”. Gastroenterology Research 2011;4:268-76.
85. Molina-Infante J, Santolaria S, Sanders DS et al. Systematic review: noncoeliac glu- ten sensitivity. Aliment Pharmacol Ther 2015;41: 807–20.
86. Irvine AJ, Chey WD, Ford AC. Screening for Celiac Disease in Irritable Bowel Syndrome: an Update systematic review and meta-analysis. Am J Gastroenterol 2017;112: 65-76.
87. Tack GJ, Verbeek WH, Schreurs MW et al. The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nat Rev Gastroenterol Hepatol 2010;7:204–13.
88. Mooney PD, Hadjivassiliou M, Sanders DS. Coeliac disease. BMJ 2014348:1561.
89. García-Manzanares Á, Lucendo AJ, González-Castillo S et al. Resolution of metabolic syndrome after following a gluten free diet in an adult woman diagnosed with celiac disease. World J Gastrointest Pathophysiol 2011;15: 35-60.
90. Molina-Infante J, Santolaria S, Montoro M et al. Non-celiac gluten sensitivity: a critical review of current evidence. Gastroenterol Hepatol. 2014;37:362-71.
91. Burger JP, de Brouwer B, IntHout J et al. Systematic review with meta-analysis: Dietary adherence influences normalization of health-related quality of life in coeliac disease. Clin Nutr 2017;36:399-406.
92. Carroccio A, Mansueto P. Response to Molina-Infante et al. Am J Gastroenterol 2013;108:451–2.
93. Carroccio A, Mansueto P, Iacono G, et al. Non-celiac wheat sensitivity diagnosed by double-blind placebocontrolled challenge: exploring a new clinical entity. Am J Gastroenterol 2012107:1898–906.
94. Molina-Infante J, Carroccio A. Suspected nonceliac sensitivity confrmed in few patients after gluten challnge in double-blind, placebo-controlled trials. Clin Gastroenterol and Hepatol. 2017;15:339-48.
95. Guandilini S, Polanco I. Nonceliac gluten sensitivity or wheat intolerance syndrome? J Pediatr. 2015;166:805-11.
96. Barmeyer C, Schumann M, Meyer T et al. Long-term response to gluten-free diet as evidence for non-celiac wheat sensitivity in one third of patients with diarrhea-dom- inant and mixed-type irritable bowel syndrome.Int J Colorectal Dis. 2017;32:29-39.
97. Vazquez-Roque MI, Camilleri M, Smyrk T, et al. A controlled trial of gluten-free diet in patients with irritable bowel syndrome diarrhea: effects on bowel frequency and intestinal function. Gastroenterology 2013;144:903-911.
98. Wahnschaffe U, Schulzke JD, Zeitz M et al. Predictors of clinical response to glu- ten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2007;5:844-50.
99. Mujagic Z, Ludidi S, Keszthelyi D, et al. Small intestinal permeability is increased in diarrhoea predominant IBS, while alterations in gastroduodenal permeability in all IBS subtypes are largely attributable to confounders. Aliment Pharmacol Ther 2014;40:288– 97.
100. Fritscher-Ravens, A, Schuppan, D, Ellrichmann, M et al. Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome. Gastroenterology 2014;147:1012–20.
101. Biesiekierski JR, Peters SL, Newnham ED et al. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology. 2013;145:320-8.
102. Vazquez-Roque MI, Camilleri M, Smyrk T et al. A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology. 2013;14:903-11.
103. Elli L, Tomba C, Branchi F, et al. Evidence for the presence of non-celiac gluten sensitivity in patients with functional gastrointestinal symptoms: results from a multicenter randomized double-blind placebo-controlled gluten challenge. Nutrients 2016;8:84.
104. Zanini B, Baschè R, Ferraresi A et al. Randomised clinical study: gluten challenge induces symptom recurrence in only a minority of patients who meet clinical criteria for non-coeliac gluten sensitivity. Aliment. Pharmacol. Ther. 2015;42: 968–76.
105. Di Sabatino A, Volta U, Salvatore C, et al. Small amounts of gluten im subjects with suspected nonceliac gluten sensitivity: a randomized, doublé-blind, placebo-controlled, cross-over trial. Clin Gastroenterol Hepatol 2015; 13: 1604-12.
106. DiGiacomo DV, Tennyson CA, Green PH et al. Prevalence of gluten-free diet adherence among individuals without celiac disease in the USA: results from the Continuous National Health and Nutrition Examination Survey 2009-2010. Scand J Gastroenterol 2013;48:921-5.
107. García-Manzanares A, Lucendo AJ. Nutritional and dietary aspects of celiac disease. Nutr Clin Pract 2011;26:163-73.
108. Volta U, Pinto-Sanchez MI, Boschetti E et al. Dietary Triggers in Irritable Bowel Syndrome: Is There a Role for Gluten?. J Neurogastroenterol Motil 2016;22:547-57.
109. Zanwar VG, Pawar SV, Gambhire PA et al. Symptomatic improvement with gluten restriction in irritable bowel syndrome: a prospective, randomized, double blinded placebo controlled trial. Intest Res 2016;14:343-50.
110. Catassi C, Fasano A. Celiac disease diagnosis: Simple rules are better than complicated algorithms. Am J Med.2010;123:691-3.
111. Volta U, de Giorgio R. New understanding of gluten sensibility. Nat Rev Gastroenterol Hepatol. 2012;28:295-9.
112. Biesiekierski JR, Newnham ED, Irving PM et al. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol 2011;106:508–14.
113. Shahbazkhani B, Sadeghi A, Malekzadeh R et al. Non-celiac gluten sensitivity has narrowed the spectrum of irritable bowel syndrome: a double-blind randomized placebo-controlled trial. Nutrients 2015;7:4542–54.
114. Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastro-intestinal symptoms: The FODMAP approach. J Gastroenterol Hepatol 2010;25:252–8.
115. Catassi G, Lionetti E, Gatti S, Catassi C. The Low FODMAP Diet: Many Question Marks for a Catchy Acronym. Nutrients 2017;9:292.
116. Biesiekierski, J.R.; Peters, S.L.; Newnham, E.D. et al. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates. Gastroenterology 2013;145:320–8.
117. Shepherd, S.J.; Parker, F.C.; Muir, J.G.; Gibson, P.R. Dietary triggers of abdominal symptoms in patients with irritable bowel syndrome: Randomized placebo-controlled evidence. Clin Gastroenterol Hepatol 2008;6:765–71.
118. Staudacher, H.M.; Whelan, K.; Irving, P.M.; Lomer, M.C. Comparison of symptom re- sponse following advice for a diet low in fermentable carbohydrates (FODMAPs) versus standard dietary advice in patients with irritable bowel syndrome. J Hum Nutr Diet 2011;24:487–95.
119. Staudacher, H.M.; Lomer, M.C.; Anderson, J.L. et al.; Whelan, K. Fermentable car- bohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr 2012;142:1510–1518.
120. De Roest, R.H.; Dobbs, B.R.; Chapman, B.A. et al. Thelow FODMAP diet improves gas- trointestinal symptoms in patients with irritable bowel syndrome: A prospective study. Int J Clin Pract. 2013;67:895–903.
121. Halmos, E.P.; Christophersen, C.T.; Bird, A.R. et al. Diets that differ in their FODMAP content alter the colon icluminal microenvironment. Gut 2015;64:93–100.
122. Pedersen, N.; Andersen, N.N.; Végh, Z.; et al. Low FODMAP diet vs. Lactobacillus- rhamnosus GG in irritable bowel syndrome. World Gastroenterol 2014;20:16215–26.
123. Chumpitazi, B.P.; Cope, J.L.; Hollister, E.B.; et al. Randomised clinical trial: Gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment Pharmacol Ther 2015;42:418–427.
124. Böhn, L.; Störsrud, S.; Liljebo, T.; et al. Dietlow in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: A randomized controlled trial. Gastroenterology 2015;149:1399–1407.
125. Whigham, L.; Joyce, T.; Harper, G.; et al. Clinical effectiveness and economic costs of group versus one-to-one education for short-chain fermentable carbohydrate restriction (low FODMAP diet) in the management of irritable bowel syndrome. J Hum Nutr Diet 2015;28:687–96.
126. McIntosh K, Reed DE, Schneider T et al. FODMAPs alter symptoms and the metabolome of patients with IBS: A randomised controlled trial. Gut. 2017;66:1241-51.
127. Peters SL, Yao CK, Philpott H et al. Randomised clinical trial: The efficacy of gut-directed hypnotherapyis similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 2016; 44:447–459.
128. Laatikainen, R.; Koskenpato, J.; Hongisto, S.M.; et al. Randomised clinical trial: Low FODMAP rye bread vs. regular rye bread to relieve the symptoms of irritable bowel syn- drome. Aliment Pharmacol Ther 2016;44:460–470.
129. Valeur, J.; Røseth, A.G.; Knudsen, T.; et al. Fecal Fermentation in Irritable Bowel Syndrome: Influence of Dietary Restriction of Fermentable Oligosaccharides, Disaccharides, Monosaccharides and Polyols. Digestion 2016;94:50–6.
130. Eswaran SL, Chey WD, Han-Markey T et al. A Randomized Controlled Trial Com- paring the Low FODMAP Diet vs. Modified NICE Guidelines in US Adults with IBS-D. Am Gastroenterol. 2016;111:1824–32.
131. Major G, Pritchard S, Murray K et al. Colon Hypersensitivity to Distension, Rather Than Excessive Gas Production, Produces Carbohydrate-Related Symptoms in Individuals With Irritable Bowel Syndrome. Gastroenterology 2017;152:124–33.
132. Hustoft TN, Hausken T, Ystad SO et al. Effects of varying dietary content of fermentable short-chain carbohydrates on symptoms, fecal microenvironment, and cytokine-profiles in patients with irritable bowel syndrome. Neurogastroenterol Motil. 2016;29:e12969.
133. Vici, G.; Belli, L.; Biondi, M.; Polzonetti, V. Gluten free diet and nutrient deficiencies: A review. Clin Nutr 2016;35:1236–41.
134. Wild, D, Robins GG, Burley VJ, Howdle PD. Evidence of high sugar intake, and low fibre and mineral intake, in the gluten-free diet. Aliment Pharmacol & Ther 2010;32:573–581.
135. Martinez-Barona S, Lerma JC, Fomes V et al. Comprehensive analysis of the nutritional profile of gluten-free products compared to their gluten-free counter parts. J Pediatr Gastroenterol Nutr 2017- 64(Suppl 1): 741.
136. Lebwohl B, Cao Y, Zong G et al. Long term gluten consumption in adults without celiac disease and risk of coronary heart disease: prospective cohort study. BMJ 2017;357:j1892.
137. Ciaccio EJ, Lewis SK, Biviano AB et al. Cardiovascular involvement in celiac disease. World J Cardiol. 2017;9:652-66.
138. Bulka CM, Davis MA, Karagas MR et al. The Unintended Consequences of a Gluten-free Diet. Epidemiology 2017;28:e24-e25.
139. Davis MA, Mackenzie TA, Cottingham KL, Gilbert-Diamond D, Punshon T, Kara- gas MR. Rice consumption and urinary arsenic concentrations in U.S. children. Environ Health Perspect 2012;120:1418–24.
140. Karagas MR, Choi AL, Oken E, et al. Evidence on the human health effects of low-level methylmercury exposure. Environ Health Perspect 2012;120:799–806.
141. European Food Safety Authority, 2014. Dietary exposure to inorganic arsenic in the European population. EFSA Journal 2014;12:3597, 68 pp. doi:10.2903/j.efsa.2014.3597
142. Bascuñán KA, Vespa MC, Araya M. Celiac disease: understanding the gluten-free diet. Eur J Nutr 2016;56:4449-59.
143. Infante, D.; Tormo, R. Risk of inadequate bone mineralization in diseases involving long-term suppression of dairy products. J Pediatr Gastroenterol Nutr 2000;30:310– 3.
144. Abrams, S.A.; Griffin, I.J.; Davila, P.M. Calcium and zinc absorption from lactose-containing and lactose-free infant formulas. Am Clin Nutr 2002;76:442–446.
145. Gröber, U.; Reichrath, J.; Holick, M.F. Live Longer with Vitamin D? Nutrients 2015; 7:1871–80.
146. Khayyat Y, Attar S. Vitamin D Deficiency in patients with irritable bowel syndrome: does it exist? Oman Med J 2015;30: 115-8.
147. Deng Y.; Misselwitz B.; Dai N.; et al. Lactose Intolerance in Adults: Biological Mech- anism and Dietary Management. Nutrients 2015;7:8020-35.
148. Shaukat, A.; Levitt, M.D.; Taylor, B.C.et al. Systematic review: Effective management strategies for lactose intolerance. Ann Intern Med 2010;152:797–803.
149. Lomer, M.C.; Parkes, G.C.; Sanderson, J.D. Reviewarticle: Lactose intolerance in clinical practice. Myths and realities. Aliment Pharmacol Ther 2008;27:93–103.
150. Brewer, M.S. Natural antioxidants: Sources, compounds, mechanisms of action, and potential applications. Compr Rev Food Sci FoodSaf 2011;10:221–47.
151. O’Keeffe M, Jansen C, Martin L, et al. Long-term impact of the low-FODMAP diet on gastrointestinal symptoms, dietary intake, patient acceptability, and health care uti- lization in irritable bowel syndrome. Neurogastroenterol Motil 2018;30:e13154.
152. Martin J, Geisel T, Maresch C et al. Inadequate nutrient intake in pa- tients with celiac disease: results from a German dietary survey. Digestion 2013;87:240-6.
153. Bingham SA, Welch AA, McTaggart A, et al. Nutritional methods in the European prospective investigation of cancer in Norfolk. Public Health Nutr 2001;4:847-58.
154. Vincenzi M, Del Ciondolo I, Pasquini E; et al. Effects of a Low FODMAP Diet and Specific Carbohydrate Diet on Symptoms and Nutritional Adequacy of Patients with Irritable Bowel Syndrome: Preliminary Results of a Single-blinded Randomized Trial. J Trans lInt Med 2017;5:120-6.
155. Altobelli E, Del Negro V, Angeletti PM, Latella G. Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis. Nutrients 2017;9:940-59.
156. Resolución WHA51.12. Promoción de la salud. En: 51ª Asamblea Mundial de la Salud, Ginebra, 11-16 de mayo de 1998. Volumen 1. Resoluciones y Decisiones, Anex- os. Ginebra, Organización Mundial de la Salud, 1998: 11-13 (documento WHA51/1998/ REC/1).
157. Resolución WHA55.23. Régimen alimentario, actividad física y salud. En: 55ª Asamblea Mundial de la Salud, Ginebra, 13-18 de mayo de 2002. Volumen 1. Resolu- ciones y Decisiones, Anexos. Ginebra, Organización Mundial de la Salud, 2002:30-32 (documento WHA55/2002/REC/1).
158. FAO. Conferencia internacional sobre nutrición: Elementos principales de estrate- gias nutricionales. Roma: FAO/OMS;1992.
159. Cozma-Petru A, Loghin F, Miere D, et al. Diet in irritable bowel syndrome: What to recommend, not what to forbid to patients!. World J Gastroenterol. 2017;23:3771-83.
160. McKenzie YA, Bowyer RK, Leach H et al. British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syn- drome in adults. J Hum Nutr Diet 2016; 29:549-575.
161. National Institute for Health and Clinical Excellence. Irritable bowel syndrome in adults: diagnosis and management. Clinical Guideline [CG61]. Published: February 2008. Last updated: February 2015. Cited 2017-01-03. Available from: https://www.nice.org. uk/guidance/cg61/resources/irritable-bowel-syndrome-in-adults-diagnosis-and-manage- ment-975562917829
162. Dhaliwal, S, Hunt, R., Doctor-patient for irritable bowel syndrome in primary care: A systematic perspective. Eur J Gastroenterol Hepatol 2004;16:1161–1166
163. Monsbakken KW, Vandvik PO, Farup PG. Perceived food intolerance in subjects with irritable bowel syndrome-- etiology, prevalence and consequences. Eur J Clin Nutr 2006;60:667–72.
164. Guo YB, Zhuang KM, Kuang L et al. Association between Diet and Lifestyle Habits and Irritable Bowel Syndrome: A Case-Control Study. Gut Liver 2015;9:649-656.
165. Mira, JJ; Guilabert, M; Sempere, L et al. Opiniones sobre el proceso asistencial de los pacientes con SII. Rev Esp Enferm Dig 2015;107:202-210.
166. Miwa H. Life style in persons with functional gastrointestinal disorders-large-scale internet survey of lifestyle in Japan. Neurogastroenterol Motil. 2012; 24:464-471.
167. Guo YB, Zhuang KM, Kuang L, Zhan Q, Wang XF, Liu SD. Association between Diet and Lifestyle Habits and Irritable Bowel Syndrome: A Case-Control Study. Gut Liver 2015; 9:649-656.
168. Mearin F, Peña E, Balboa A. Importancia de la dieta en el síndrome del intestino irritable. Gastroenterol Hepatol 2014;37:302-10.
169. Lacy BE, Weiser K, Noddin L, et al. Irritable bowel síndrome: patients attitudes, concerns and level of knowledge. Aliment Pharmacol Ther 2007;25:1329-41.
170. Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Quarterly 1996;74:511-544.
171. Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Effective Clin Practice 1998;1:2-4.
172. Wagner EH, Davis C, Schaefer J et al. A survey of leading chronic disease management programs: are they consistent with the literature? Managed Care Quart 1999;7:56-66.
173. Coleman K, Austin BT, Brach C et al. Evidence on the Chronic Care Model in the New Millennium. Health Affairs. 2009; 28:75-85.
174. Barr VJ, Robinson S, Marin-Link B et al. The expanded chronic care model: an integration of concepts and strategies from popu- lation health promotion and the chronic care model. Hospital Quarterly 2003;7:73-82.
175. WHO. Innovative care for chronic conditions: building blocks for action. Global re- port WHO/NMC/CCH. Ginebra: WHO; 2002.
176. Epping-Jordan JE, Pruitt SD, Bengoa R, Wagner EH. Improving the quality of health care for chronic conditions. Quality and Safety in Health Care 2004;13:299-305.
177. Nuño R. Atención innovadora a las condiciones crónicas: más necesaria que nunca, Revista de Innovación Sanitaria y Atención Integrada. RISAI 2009;1:1-8.
178. Mearin F, Ciriza C, Mínguez M et al. Guía de Práctica clínica: síndrome del intesti- no irritable con estreñimiento y estreñimiento funcional en adultos. Rev Esp Enferm Dig 2016;108:332-63.
179. Halpert A, Dalton CB, Palsson O, Morris C, Hu Y, Bangdiwala S, Hankins J, Norton N and Drossman D: National Survey on Patient Educational Needs in IBS and Development and Validation of the Patient Educational Needs Questionnaire (PEQ): What patients know about irritable bowel syndrome (IBS) and what they would like to know. National Survey on Patient Educational Needs in IBS and development and validation of the Pa tient Educational Needs Questionnaire (PEQ). Am J Gastroenterol 2007;102:1972–82.
180. Flik CE, van Rood YR, de Wit NJ. Systematic review: knowledge and educational needs of patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2015;27:367-71.
181. Halpert A, Dalton CB, Palsson O, et al. Irritable bowel syndrome patients’ ideal ex- pectations and recent experiences with healthcare providers: a national survey. Dig Dis Sci 2010;55:375-83.
182. Håkanson C. Everyday life, healthcare, and self-care management among people with irritable bowel syndrome: an integrative review of qualitative research. Gastroen- terol Nurs. 2014;37:217-25.
183. Delgado-Quiñones EG, Cervantes-Sánchez P, Hernández-Calderón J et al. Irritable Bowel Syndrome, a condition with an integrated approach. Rev Med 2015;4:300-6.
184. Mazzawi T, Hausken T, Gundersen D, El-Salhy M. Effects of dietary guidance on the symptoms, quality of life and habitual dietary intake of patients with irritable bowel syndrome. Mol Med Rep 2013;8:845-52.
185. Ostgaard H, Hausken T, Gundersen D, El-Salhy M. Diet and effects of diet manage- ment on quality of life and symptoms in patients with irritable bowel syndrome. Mol Med Rep 2012;5:1382-90.
186. Saito YA, Prather CM, Van Dyke CT, et al. Effects of multidisciplinary education on outcomes in patients with irritable bowel syndrome. Clin Gastroenterol Hepatol.2004;2:576-84.
187. Ringström G, Störsrud S, Posserud I,et al..Structured patient education is superior to written information in the management of patients with irritable bowel syndrome: a randomized controlled study.Eur J Gastroenterol Hepatol 2010;22:420-8.
188. El-Salhy M, Lillebø E, Reinemo A, Salmelid L and Hausken T: Effects of a health program comprising reassurance, diet management, probiotics administration and reg- ular exercise on symptoms and quality of life in patients with irritable bowel syndrome. Gastroenterol Insights 2010;2:1–6.